Portal del Investigador
Hippo/YAP1 as a predictor of therapy and novels target for precision medicine using gastric cancer patients-derived organoids.
Más información
| Fecha de publicación: | 2022 |
| Objetivos: | To evaluate the potential of YAP1 for predicting response to standard therapy and propose Yap1 inhibition as a targeted therapy for precision medicine in genomically stable gastric cancer |
| Instrumento: | FONDECYT |
| Año de Inicio/Término: | 2022-2026 |
| Financiamiento/Sponsor: | CONICYT |
| Rol del Usuario: | INVESTIGADOR(A) RESPONSABLE |
| DOI: |
1221253 |